Cargando…
Novel guanidinoacetate methyltransferase (GAMT) mutation associated with cerebral creatine deficiency syndrome in a Syrian child: a case report
Guanidinoacetate methyltransferase (GAMT) deficiency, also known as cerebral creatine deficiency syndrome type 2 (CCDS2), is an uncommon disease caused by an innate genetic defect in the metabolic pathway of creatine inherited in an autosomal recessive manner. It is a rare cause of neurological regr...
Autores principales: | Alhomsi, Dima, Abdalsalam, Dania, Sulaiman, Rama, Bakleh, Sameer, Alasmar, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205335/ https://www.ncbi.nlm.nih.gov/pubmed/37228909 http://dx.doi.org/10.1097/MS9.0000000000000385 |
Ejemplares similares
-
Guanidinoacetate Methyltransferase (GAMT) Deficiency, A Cerebral Creatine Deficiency Syndrome: A Rare Treatable Metabolic Disorder
por: Yoganathan, Sangeetha, et al.
Publicado: (2020) -
Case Series of Creatine Deficiency Syndrome due to Guanidinoacetate Methyltransferase Deficiency
por: Narayan, Vinu, et al.
Publicado: (2020) -
Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities
por: Khoja, Suhail, et al.
Publicado: (2022) -
Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF
por: Jomura, Ryuta, et al.
Publicado: (2022) -
Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency
por: Rossi, Luigia, et al.
Publicado: (2021)